Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
This guide highlights dividend ETFs with the lowest expense ratios and explains how expense structures influence long-term performance.
27,554 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
As tax day approaches, millions await refunds. This guide on refund tracker explained: what to know outlines timing, ...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
Peabody Energy shares fell nearly 6% after a quarterly report that missed profitability targets. This article breaks ...
Three under-$10 energy names are drawing attention as one yields 8.8%, another is up 83% in a year, and market chatte...
XRP surged to a two-month peak, while on-chain activity jumped, signaling renewed investor interest. Analysts say the...
Privacy-focused crypto Zcash is quietly advancing features that could challenge Bitcoin and Ethereum. This in-depth g...
Bitcoin faces a tight range as bulls defend key support near $75K. A brief rebound could unfold, but a sustained upmo...
MasterBrand has closed its all-stock merger with American Woodmark, creating North America's largest cabinet supplier...
When a company’s CFO reports a large stock sale, investors want to know what it implies. This article breaks down the...
President Trump announced Bill Pulte, longtime chair of the housing giants Fannie Mae and Freddie Mac, as acting dire...
As the World Cup arrives in North America, steep prices are prompting many fans to stay home. Industry analysts say f...